Investing Profile

Raj Parekh

InvestorVC
General Partner at Advent Life Sciences
Photo of Raj Parekh, General Partner at Advent Life Sciences

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
Advent Life Sciences General Partner
$25K - $5.0M
$1M
12
CompanyStageDateRound SizeTotal Raised
Rappta Therapeutics
Series AOct 2020$11M
$11M
Co-investors: Beat Steffen (Novartis Venture Fund)
Zikani Therapeutics
Series AApr 2020$8M
Series UnknownApr 2018$20M
$28M
Amphista Therapeutics
Series AApr 2020$8M
$61M
Co-investors: Satish Jindal (Advent Life Sciences), Florian Müllershausen (Novartis Venture Fund), Rogier Rooswinkel (Forbion)
Levicept
Series AOct 2014$16M
$16M
NeRRe Therapeutics
Series ADec 2012$18M
$18M
F2G
Series UnknownSep 2012$30M
$160M
Co-investors: Anja Konig (Novartis Venture Fund), Nanna Luneborg (Forbion), Joseph Anderson (Soffinova Partners), Maha Katabi (Sofinnova Investments)
Biocartis
Series BApr 2010$40M
Series AOct 2009$15M
$55M
Avila Therapeutics
Series BJul 2009$30M
Series AAug 2007
$30M
Co-investors: Amir Nashat (Polaris Partners), Bruce Booth (Atlas Venture), Vicki Sato (ARCH Venture Partners)
Chairman, Co-Founder and Managing Director Redwood Ventures1998 - Present